Edition:
United States

Lexicon Pharmaceuticals Inc (LXRX.OQ)

LXRX.OQ on NASDAQ Stock Exchange Global Select Market

7.26USD
14 Dec 2018
Change (% chg)

-- (--)
Prev Close
$7.26
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
148,050
52-wk High
$13.97
52-wk Low
$6.76

Chart for

About

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of breakthrough treatments for human disease. Its drug programs include XERMELO (telotristat ethyl), sotagliflozin, LX2761 and LX9211. It also has a number of additional compounds into various stages of... (more)

Overall

Beta: 0.15
Market Cap(Mil.): $1,239.53
Shares Outstanding(Mil.): 105.58
Dividend: --
Yield (%): --

Financials

  LXRX.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -1.33 -- --
ROI: -42.10 9.01 14.96
ROE: -85.52 10.15 16.52

Earnings vs. Estimates